Dr. Reddy’s Laboratories of Princeton, N.J., is recalling about 21,400 blister packages of Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg.
The products are prescription medications that were labeled and distributed by Dr. Reddy’s for institutional use only.
The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.
The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.
No incidents or injuries have been reported.
This recall involves blister packages of prescription medications. The name and strength of the medication, “For Institutional Use only,” “Rx Only,” lot number and expiration date are printed on the outside of the package as well as on the individual blister units.
The Dr. Reddy’s logo and NDC number are printed on the outside of the package.
A list of the recalled medications may be found here.
The recalled products, manufactured in India, were sold to wholesalers by Dr. Reddy's beginning in 2018.
Ultimately, they could have been sold to consumers at retail pharmacies in the U.S. at varying prices based on quantities prescribed, health insurance terms and other factors.
What to do
Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy’s for a full refund.
Consumers may contact Dr. Reddy’s toll-free at (888) 375-3784 from 8 a.m. to 8 p.m. (ET) Monday through Friday, or online at www.drreddys.com and click on “Recalls” at the top of the page for more information.
Report incidents related to children accessing or ingesting these prescription medications to www.SaferProducts.gov.